Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
3.160
+0.300 (10.49%)
At close: Aug 4, 2026, 4:00 PM EDT
3.160
0.00 (0.00%)
After-hours: Aug 4, 2026, 4:10 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $74.11 million as of August 4, 2026. Its market cap has decreased by -53.54% in one year.
Market Cap
74.11M
Enterprise Value
70.69M
1-Year Change
-53.54%
Ranking
Category
Stock Price
$3.16
ChartMarket Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $74.11M, a decrease of -76.26%. That is a compound annual growth rate of -36.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 74.11M | -46.72% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 68.27M |
| XBiotech | 67.99M |
| Spero Therapeutics | 67.74M |
| OS Therapies | 67.70M |
| LeonaBio | 66.32M |
| MediciNova | 65.46M |
| Cingulate | 64.52M |
| Pliant Therapeutics | 64.40M |